Skip to main content

stock

PBSV · Pharma-Bio Serv, Inc.

What Pharma-Bio Serv, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live PBSV price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PBSV.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Services-Management Consulting Services (SIC 8742)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
22,901,692 as of 2026-09-10 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
32.3%
Operating
-1.6%
Net
2.7%

Returns

ROE
2.4%
ROA
2.2%

Health

Current ratio
11.3x
Debt/equity
—

Deep value

NCAV
$10.24M
NCAV per share
$0.45
Price/NCAV
Locked
NNWC
$2.34M
NNWC per share
$0.10
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-07-31; balance sheet at 2026-07-31.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-07-31$2.34M$691,734-$71,812-$14,219
10-Q filed 2026-09-14
2026-04-30$2.70M$902,041$144,676$232,986
10-Q filed 2026-06-15
2026-01-31$2.29M$722,374-$94,535$32,860
10-Q filed 2026-03-17
2025-10-31$2.15M$748,935-$133,272-$102
10-K filed 2026-01-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-07-31$1.96M$574,262-$313,877-$204,250
10-Q filed 2026-09-14
2025-04-30$2.42M$818,726-$98,322$95,353
10-Q filed 2026-06-15
2025-01-31$2.47M$768,109-$92,191$8,536
10-Q filed 2026-03-17
2024-10-31$2.33M$726,570-$154,130$16,111
10-K filed 2026-01-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assets
$11.44M
Equity
$10.44M

Balance as of 2026-07-31.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-10-31$9.00M-$637,662-$100,463-$221,530
2024-10-31$9.51M-$1.29M-$777,619-$726,444
2023-10-31$16.98M$1.12M$1.31M$1.88M
2022-10-31$19.40M$1.17M$1.01M$573,188
2021-10-31$20.12M-$3.85M-$2.09M$793,997
2020-10-31$21.56M$2.23M$2.05M$1.46M
2019-10-31$19.51M$1.70M$2.09M-$2.27M
2018-10-31$17.80M-$1.26M$1.28M$3.60M
2017-10-31$13.30M-$777,818-$1.41M-$979,640
2016-10-31—-$91,759-$256,575-$1.10M

Company filings

events

  • Results

    Results
    Sep 148-K
  • Results

    Results
    Jun 158-K
  • Shareholder vote results

    Shareholder vote results
    May 158-K
  • Results

    Results
    Mar 178-K
  • Results

    Results
    Jan 298-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named PBSV, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about PBSV.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about PBSV.

nakagai

Signals on PBSV come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PBSV board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.